Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

epithelial

epithelial is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 44
News articles 0
Drug details — epithelial
Class
—
Route
—
Patents
20
Programs
44
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

epithelial is an FDA-listed pharmaceutical active ingredient.

Key facts

INN epithelial

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. 2024/4031 Phase 3 · George Institute for · Patients with primary HPV high-grade squamous intra-epitheli
  2. 213350/3000-03-005 Phase 3 · TESARO Bio Netherlands · Stage 3 or 4 Non-mucinous Epithelial Ovarian Cancer
  3. ALKS 4230-007 Phase 3 · Createrna Science and · Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Pr
  4. CISPLATIN Phase 3 · Ningbo Cancer Hospital · Ovarian epithelial cancer : intraperitoneal resectable relap
  5. CO-338-087 Phase 3 · pharma& · Ovarian epithelial cancer, Malignant peritoneal neoplasm, ad
  6. CORT125134-556 Phase 3 · CORCEPT THERAPEUTICS · Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian,
  7. D8991C00001 Phase 3 · AstraZeneca · Advanced Platinum-resistant Epithelial Ovarian Cancer
  8. DUO-O/D081RC00001 Phase 3 · AstraZeneca · Newly diagnosed advanced (FIGO stage III-IV) high grade epit

Related patents

Browse patents

  1. US 12263169

    Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12202841

    Therapeutic agents for enhancing epithelial and/or endothelial barrier function

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11890340

    Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11793810

    Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11213526

    Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators

    Expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11186873

    Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10722523

    Chemoimmunotherapy for epithelial cancer

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10663473

    Method of identifying a status of a mucosal intestinal epithelial barrier to improve treatment of inflammatory bowel disease

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10329353

    Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating tumor cells

    Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10034916

    Methods of treating a retinal disease by retinal pigment epithelial stem cells

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9624304

    Antibodies which bind to epithelial membrane protein 2 (EMP2)

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9464135

    Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)

    Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8748176

    Generation of choroid plexus epithelial cells from human embryonic stem cells

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8481313

    Retinal pigment epithelial stem cells

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8343481

    Method of preparing lung alveolar epithelial type II cells derived from embryonic stem cells

    Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8198254

    Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8030012

    Id-1 and Id-2 genes and products as markers of epithelial cancer

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7824695

    Delivery of proteins across polar epithelial cell layers

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7429457

    Id-1 and Id-2 genes and products as markers of epithelial cancer

    Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7026291

    Epithelial cell specific growth factor, keratinocyte growth factor (KGF)

    Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is epithelial?

epithelial is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.